Principal Financial Group Inc Zoetis Inc. Transaction History

Principal Financial Group Inc

$160 Billion
Q2 2024

A detailed history of Principal Financial Group Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 2,026,031 shares of ZTS stock, worth $395 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

2,026,031

Previous 1,901,484 6.55%

Holding current value

$395 Million

Previous $322 Million 9.16%

% of portfolio

0.22%

Previous 0.2%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$145.54 - $178.83 $18.1 Million - $22.3 Million	124,547 Added 6.55%	2,026,031 $351 Million
Q1 2024 Apr 29, 2024	SELL	$165.67 - $199.94 $12.3 Million - $14.9 Million	-74,513 Reduced 3.77%	1,901,484 $322 Million
Q4 2023 Feb 07, 2024	SELL	$151.44 - $200.09 $22.7 Million - $30 Million	-150,093 Reduced 7.06%	1,975,997 $390 Million
Q3 2023 Nov 02, 2023	BUY	$167.14 - $192.77 $1.7 Million - $1.96 Million	10,153 Added 0.48%	2,126,090 $370 Million
Q2 2023 Aug 07, 2023	SELL	$160.94 - $186.23 $19.3 Million - $22.3 Million	-119,926 Reduced 5.36%	2,115,937 $364 Million
Q1 2023 May 09, 2023	SELL	$145.48 - $175.02 $2.24 Million - $2.69 Million	-15,392 Reduced 0.68%	2,235,863 $372 Million
Q4 2022 Feb 09, 2023	BUY	$131.14 - $157.47 $9.62 Million - $11.5 Million	73,322 Added 3.37%	2,251,255 $330 Million
Q3 2022 Nov 09, 2022	BUY	$148.29 - $182.55 $33.4 Million - $41.2 Million	225,510 Added 11.55%	2,177,933 $323 Million
Q2 2022 Aug 10, 2022	BUY	$155.97 - $200.09 $54.5 Million - $69.9 Million	349,478 Added 21.8%	1,952,423 $336 Million
Q1 2022 May 09, 2022	BUY	$181.39 - $234.03 $64.3 Million - $82.9 Million	354,224 Added 28.37%	1,602,945 $302 Million
Q4 2021 Feb 09, 2022	BUY	$193.69 - $247.03 $4.86 Million - $6.2 Million	25,092 Added 2.05%	1,248,721 $303 Million
Q3 2021 Nov 09, 2021	BUY	$189.29 - $209.69 $5.38 Million - $5.96 Million	28,430 Added 2.38%	1,223,629 $238 Million
Q2 2021 Aug 10, 2021	BUY	$155.9 - $187.99 $3.22 Million - $3.88 Million	20,661 Added 1.76%	1,195,199 $223 Million
Q1 2021 May 10, 2021	BUY	$144.0 - $169.39 $77.7 Million - $91.4 Million	539,555 Added 84.97%	1,174,538 $185 Million
Q4 2020 Feb 08, 2021	SELL	$157.07 - $174.35 $5.1 Million - $5.66 Million	-32,456 Reduced 4.86%	634,983 $105 Million
Q3 2020 Nov 06, 2020	SELL	$137.1 - $165.37 $6.29 Million - $7.59 Million	-45,895 Reduced 6.43%	667,439 $110 Million
Q2 2020 Aug 05, 2020	BUY	$111.92 - $142.53 $4.3 Million - $5.47 Million	38,400 Added 5.69%	713,334 $97.8 Million
Q1 2020 May 12, 2020	BUY	$92.66 - $144.94 $60,414 - $94,500	652 Added 0.1%	674,934 $79.4 Million
Q4 2019 Feb 05, 2020	SELL	$116.25 - $133.25 $2.38 Million - $2.73 Million	-20,498 Reduced 2.95%	674,282 $89.2 Million
Q3 2019 Nov 13, 2019	SELL	$112.57 - $128.43 $958,308 - $1.09 Million	-8,513 Reduced 1.21%	694,780 $86.6 Million
Q2 2019 Aug 12, 2019	BUY	$97.98 - $114.28 $434,051 - $506,260	4,430 Added 0.63%	703,293 $79.8 Million
Q1 2019 May 10, 2019	SELL	$81.56 - $100.67 $13.3 Million - $16.4 Million	-162,510 Reduced 18.87%	698,863 $70.4 Million
Q4 2018 Feb 14, 2019	SELL	$79.28 - $95.27 $5.14 Million - $6.17 Million	-64,805 Reduced 7.0%	861,373 $73.7 Million
Q3 2018 Nov 14, 2018	SELL	$83.5 - $93.23 $3.91 Million - $4.36 Million	-46,772 Reduced 4.81%	926,178 $84.8 Million
Q2 2018 Aug 13, 2018	BUY	$79.9 - $89.2 $15.7 Million - $17.5 Million	196,450 Added 25.3%	972,950 $0
Q1 2018 May 14, 2018	BUY	$71.51 - $84.69 $746,993 - $884,671	10,446 Added 1.36%	776,500 $64.8 Million
Q4 2017 Feb 13, 2018	BUY	$63.24 - $72.8 $1.78 Million - $2.05 Million	28,200 Added 3.82%	766,054 $55.2 Million
Q3 2017 Nov 02, 2017	BUY	$59.73 - $65.4 $44.1 Million - $48.3 Million	737,854	737,854 $47 Million

Others Institutions Holding ZTS

# of Institutions

1,897

Shares Held

423M

Call Options Held

1.15M

Put Options Held

1.2M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $91.2B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Zoetis Inc. Transaction History